4068-58-0

Basic information

• Product Name: 3-Bromo-5-chloro salicylic acid
• Synonyms: BENZOIC ACID, 3-BROMO-5-CHLORO-2-HYDROXY
• CAS NO: 4068-58-0
• Molecular Formula: C₇H₄BrClO₃
• Molecular Weight: 251.47
• Mol File: 4068-58-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 326.1 °C at 760 mmHg
• Flash Point: 151 °C
• Appearance: /
• Density: 1.956 g/cm³
• CAS DataBase Reference: 3-Bromo-5-chloro salicylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-5-chloro salicylic acid(4068-58-0)
• EPA Substance Registry System: 3-Bromo-5-chloro salicylic acid(4068-58-0)

Safety Data

• Hazardous Substances Data: 4068-58-0(Hazardous Substances Data)

Upstream product

• 69-72-7 salicylic acid 
• 321-14-2 5-chloro-2-hydroxybenzoic acid 
• 19652-32-5 3-bromo-5-chlorosalicylaldehyde 

Downstream Products

• 1262231-37-7 C₂₃H₂₃NO₆ 
• 1422006-24-3 C₁₈H₁₄O₅ 
• 1262230-99-8 N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine 
• 65851-97-0 methyl 3-bromo-5-chloro-2-methoxybenzoate 
• 825648-25-7 2-(2-chlorophenylcarbamoyl)-6-bromo-4-chlorophenyl acetate 
• 343948-71-0 2-acetoxy-3-bromo-5-chlorobenzoic acid 

Relevant articles and documents

Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines

The synthesis of 6-aryl, 8- aryl, and 8-aryl-6-chloro-2-morpholino-1,3-benzoxazines with potent activity against PI3K and DNA-PK is described. Synthesis of thirty one analogues was facilitated by an improved synthesis of 3-bromo-2-hydroxybenzoic acid 13 by de-sulphonation of 3-bromo-2-hydroxy-5-sulfobenzoic acid 12 en route to 2-methylthio-substituted-benzoxazine intermediates 17-19. From this series, compound 20k (LTURM34) (dibenzo[b,d]thiophen-4-yl) (IC50 = 0.034 μM) was identified as a specific DNA-PK inhibitor, 170 fold more selective for DNA-PK activity compared to PI3K activity. Other compounds of the series show markedly altered selectivity for various PI3K isoforms including compound 20i (8-(naphthalen-1-yl) a potent and quite selective PI3Kδ inhibitor (IC50 = 0.64 μM). Finally, nine compounds were evaluated and showed antiproliferative activity against an NCI panel of cancer cell lines. Compound 20i (8-(naphthalen-1-yl) showed strong anti-proliferative activity against A498 renal cancer cells that warrants further investigation.

Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof

The polymorphic forms of the compound of Formula I, the preparation thereof including the preparation of the intermediates, the pharmaceutical compositions thereof and the uses of a polymorph above in the manufacture of medicaments for treating a disease,

NEW COMPOUNDS II

Compounds of formula I, wherein Y = H, -OH, halo, -OC1-6alkyl, -C1-6alkyl, the two latter optionally substituted with halo, -CN, -OH, -CF3, -NH2; Rl = -C3-6cycloaUcyl, heterocycloalkyl, aryl, alkylaryl, heteroaryl, -C3-6-alkyl, optionally substituted with halo, -CN, -OH, -CF3, -OCF3, -NH2, -CONH2; M = -C(O)-, -C(H2)-, -CH(OR3)-, -N(Ra)-, -S(O)r-, heteroaryl and a bond; wherein Ra = H or C1-6alkyl and r = 0, 1 or 2; R2 = H, halo, -CN, or D = -C1-6alkyl, C3-6cycloalkyl, heterocycloalkyl, -N(CH3)2, aryl, alkylaryl, heteroaryl, and heterocyclic groups; where D is optionally substituted with G = halo, -NO2, -CN, -OH, -CF3, -OCF3, -NH2, -CONH2, -COOH, aryl, heteroaryl, heterocyclic groups, -C1-6alkyl, -C1-6alkoxy, heterocycloalkyl, and C1-6alkylcarboxylate; where D may be connected to G by L = -C(O)-, -S-, or -S(O2)-; and G may be further substituted with substituents selected from halo, -NO2, -CN, -OH, -CH3, -OCH3, -CF3, -OCF3, -NH2, -CONH2, -COOH, C1-6alkylcarboxylate; and R3 = -OH or C1-6alkoxy.